Jaihind Industries Ltd has announced a major strategic pivot, proposing to raise Rs 99.32 crore through the issuance of convertible warrants. The capital infusion will fund a significant entry into the healthcare sector, following its recent 78% acquisition of Wellness & Medicial Oasisz Private Limited. The company also confirmed leadership changes, with Prasham Kumar Doshi appointed as the new Managing Director.
Jaihind Industries Announces Rs 99 Crore Fundraise and Healthcare Pivot
- Rs 99.32 crore to be raised via preferential issue of convertible warrants.
- 78% stake acquired in Wellness & Medicial Oasisz Private Limited.
Reader Takeaway: The significant capital raise signals a major business model transformation; watch execution of healthcare diversification.
What just happened
Jaihind Industries Ltd (formerly Jaihind Synthetics) has released its FY 2025-26 Annual Report, outlining a major strategic shift. The Board has approved the issuance of 2,36,48,000 convertible warrants at Rs 42 each, totaling Rs 99.32 crore. This move is designed to bankroll an aggressive expansion into the healthcare sector and scale existing textile operations.
Why this matters
The company is pivoting from its historical textile trading roots toward high-growth service segments. The scale of the fundraise is substantial compared to the company’s recent performance, where it reported a total income of Rs 19.92 lakh for FY 2025-26. The shift includes the acquisition of a 78% stake in Wellness & Medicial Oasisz Private Limited, establishing its foothold in hospital infrastructure and diagnostics.
Strategic Developments
- Healthcare Focus: Rs 65 crore of the proceeds is earmarked for hospital infrastructure, equipment, and diagnostic facilities.
- Business Expansion: Rs 20 crore is allocated to textile/garment trading and Rs 10 crore toward working capital.
- Capital Structure: To support these moves, the company has increased its authorised share capital from Rs 9 crore to Rs 30 crore.
Leadership Update
The company is undergoing a management transition. Following the passing of Mr. Dinesh Doshi, Mr. Prasham Kumar Doshi has been appointed as the new Managing Director for a five-year term effective August 19, 2026. Mr. Pramod Ramsurat Yadav continues his role as Company Secretary.
Risks to watch
Investors should monitor the integration risks associated with the new healthcare subsidiary and the successful conversion of the warrants. The company’s ability to deploy capital efficiently across new hospital assets compared to its historical operating scale will be a primary performance indicator.
What to track next
Watch for updates on the deployment schedule of the Rs 65 crore healthcare investment and the operational progress of Wellness & Medicial Oasisz Private Limited.